Skip to main content

New Products

  • Goody develops clip-in decorative hair jewelry extensions

    ATLANTA — Goody, a maker of hair accessories and styling tools, has taken its Simple Styles line to the next level with the new Clip-Ins hair jewelry extensions set to launch in the fall.

    The new Clip-Ins are the next generation to the trend of women wearing dangling extension hair accessories: feathers, colored hair, chains.  Featuring silver, gold or hematite chains and adorned with charms or jewels, these clip-in accessories can add sparkle to any style.   

  • FDA approves opioid addiction treatment

    RICHMOND, Va. — The Food and Drug Administration has approved a drug made by Reckitt Benckiser Pharmaceuticals for treating addiction to opioid drugs, the drug maker said.

    Reckitt Benckiser announced the approval of Suboxone (buprenorphine and naloxone) sublingual film in the 4 mg and 12 mg strengths, used for the maintenance treatment of dependence on prescription opioid painkillers and heroin. Addiction to opioid drugs is a growing epidemic in the United States, the company said.

  • Murad develops new Pore & Line Minimizing Hydrator

    EL SEGUNDO, Calif. — Murad, whose skin care products are available at such retailers as Ulta Beauty and Sephora, has announced the addition of the new Pore & Line Minimizing Hydrator to its Anti-Aging Acne Line, which was created to simultaneously reduce acne and aging concerns.

  • 'Old-school' Peanut Chews is back, with new packaging, ad campaign

    The Philadelphia chocolate-and-peanut bar that started as a World War I ration is back — even though it didn't really go anywhere. Candy company Just Born announced that it has overhauled its Peanut Chews' brand image to better reflect its roots.

  • Prasco, Sunovion enter agreement over Xopenex authorized generic

    CINCINNATI, Ohio — Prasco Labs is distributing an authorized generic version of a respiratory drug under an agreement with the branded drug's manufacturer.

  • Sanofi Pasteur announces availability of Sklice head lice lotion

    SWIFTWATER, Pa. — Sanofi's vaccine's division has launched a new treatment for head lice, the company said Monday.

    Sanofi Pasteur announced the availability of Sklice (ivermectin) lotion in the 0.5% strength. The drug is approved for patients ages 6 months and older.

    The company said head lice cases have increased rapidly in the United States, affecting between 6 million and 12 million children ages 3 to 11 years each year.

  • PharmaSmart, Microlife partner to provide integrated screening system

    ROCHESTER, N.Y. — PharmaSmart International and Microlife will offer an integrated assessment of cardiovascular health risk factors to healthcare providers under a new partnership between the companies.

  • UrgentRx to introduce allergy SKU in October

    DENVER — UrgentRx will be adding an allergy relief product to its portfolio of on-the-go OTC solutions in October, the company recently announced.

    The new product, called Allergy Attack Relief to Go and formulated with 25 mg of diphenhydramine, will be available as a raspberry-flavored powder that will retail for a suggested $1.39.

X
This ad will auto-close in 10 seconds